- Home
- DEI vs PTGX Comparison
DEI vs PTGX Comparison
Compare DEI & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DEI
- PTGX
- Stock Information
- Founded
- DEI 1971
- PTGX 2006
- Country
- DEI United States
- PTGX United States
- Employees
- DEI N/A
- PTGX N/A
- Industry
- DEI Real Estate Investment Trusts
- PTGX Biotechnology: Pharmaceutical Preparations
- Sector
- DEI Real Estate
- PTGX Health Care
- Exchange
- DEI Nasdaq
- PTGX Nasdaq
- Market Cap
- DEI 2.5B
- PTGX 3.3B
- IPO Year
- DEI 2006
- PTGX 2016
- Fundamental
- Price
- DEI $16.18
- PTGX $53.00
- Analyst Decision
- DEI Buy
- PTGX Strong Buy
- Analyst Count
- DEI 9
- PTGX 9
- Target Price
- DEI $18.13
- PTGX $67.11
- AVG Volume (30 Days)
- DEI 1.7M
- PTGX 923.4K
- Earning Date
- DEI 08-05-2025
- PTGX 08-05-2025
- Dividend Yield
- DEI 4.72%
- PTGX N/A
- EPS Growth
- DEI N/A
- PTGX N/A
- EPS
- DEI 0.32
- PTGX 0.86
- Revenue
- DEI $995,663,000.00
- PTGX $207,801,000.00
- Revenue This Year
- DEI $1.41
- PTGX N/A
- Revenue Next Year
- DEI $2.29
- PTGX $53.09
- P/E Ratio
- DEI $50.91
- PTGX $61.48
- Revenue Growth
- DEI 1.93
- PTGX N/A
- 52 Week Low
- DEI $12.39
- PTGX $32.50
- 52 Week High
- DEI $20.50
- PTGX $60.60
- Technical
- Relative Strength Index (RSI)
- DEI 67.03
- PTGX 53.99
- Support Level
- DEI $15.21
- PTGX $49.38
- Resistance Level
- DEI $16.25
- PTGX $51.51
- Average True Range (ATR)
- DEI 0.45
- PTGX 2.02
- MACD
- DEI 0.09
- PTGX -0.39
- Stochastic Oscillator
- DEI 91.58
- PTGX 46.09
About DEI Douglas Emmett Inc.
Douglas Emmett Inc is an integrated, self-administered, and self-managed REIT. It is an owner and operator of office and multifamily properties located in coastal submarkets in Los Angeles and Honolulu. The group focuses on owning, acquiring, developing, and managing a substantial market share of office properties and multifamily communities in neighborhoods with supply constraints, high-end executive housing, and key lifestyle amenities. Its properties are located in the Beverly Hills, Brentwood, Burbank, Century City, Olympic Corridor, Santa Monica, Sherman Oaks/Encino, Warner Center/Woodland Hills and Westwood submarkets of Los Angeles County, California, and in Honolulu, Hawaii. It has two business segments, the office segment and the multifamily segment.
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.